Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The small non-coding RNA landscape of prostate epithelium

ABSTRACT: The small non-coding RNA landscape of prostate epithelium

PROVIDER: PRJNA512612 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8387820.fastq.gz	Fastqsanger.gz
	SRR8387821.fastq.gz	Fastqsanger.gz
	SRR8387822.fastq.gz	Fastqsanger.gz
	SRR8387823.fastq.gz	Fastqsanger.gz
	SRR8387814.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

The small non-coding RNA landscape of prostate epithelium

Project description:Vitamin D, a hormone that acts through the nuclear vitamin D receptor (VDR), upregulates anti-tumorigenic microRNA in prostate epithelium. This may contribute to the lower levels of aggressive prostate cancer (PCa) in patients with high serum vitamin D. Expression of other small non-coding RNAs (ncRNAs) in prostate epithelium and their potential regulation by vitamin D are uncharacterized. Laser capture microdissection (LCM) followed by small-RNA sequencing was used to identify ncRNA in the prostate epithelium of tissues from a vitamin D-supplementation trial. We compared the expression profiles to small-RNA sequencing data from primary prostate epithelial cells and publically-available benign whole prostate. Application of LCM to isolate epithelium promoted sample homogeneity and captured more diversity in ncRNA species. An abundance of PIWI-interacting RNAs (piRNAs) was detected in normal prostate epithelium, which increased under high vitamin D conditions.

2019-04-01 | GSE124589 | GEO

Urinary exosomal small non-coding RNA expression of prostate cancer patients

Project description:Small non-coding RNA profiling of urine exosomal total RNA from patients with or without prostate cancer were performed using Affymetrix GeneChip miRNA 4.0 to identify small non-coding RNA profile that can be used for prostate cancer diagnosis.

2020-07-29 | GSE138740 | GEO

Urinary exosomal small non-coding RNA expression of prostate cancer patients

Project description:Small non-coding RNA profiling of urine exosomal total RNA from patients with or without prostate cancer were performed using Affymetrix miRNA Gene-Chip 4.0 to identify small non-coding RNA proflie that can be used for prostate cancer diagnosis.

2020-10-08 | GSE159177 | GEO

A landscape of mouse mitochondrial small non-coding RNAs

Project description:A landscape of mouse mitochondrial small non-coding RNAs

| PRJEB61863 | ENA

Urinary exosomal small non-coding RNA expression of prostate cancer patients

Project description:Urinary exosomal small non-coding RNA expression of prostate cancer patients

| PRJNA667911 | ENA

Urinary exosomal small non-coding RNA expression of prostate cancer patients

Project description:Urinary exosomal small non-coding RNA expression of prostate cancer patients

| PRJNA576942 | ENA

Identification of novel long non-coding RNAs in prostate cancers

2015-03-02 | GSE59745 | GEO

Identification of novel long non-coding RNAs in prostate cancers

Project description:Long non-coding RNAs show highly tissue and disease specific expression profiles. We analyzed prostate cancer and normal adjacent prostate samples to identify cancer-specific transcripts and found 334 candidates, of which 15 were validated by RT-PCR. 8 Prostate cancer samples from radical prostatectomies, 12 samples from normal adjacent prostate, 12 samples from lymph node metastasis and 10 samples from transurethral resection of the prostrate were included in this study. These samples contained more than 70% cancer and less than 30% stromal tissue.

2015-03-02 | E-GEOD-59745 | biostudies-arrayexpress

Integrative identification of non-coding regulatory regions driving metastatic prostate cancer [CRISPR]

Project description:Large-scale sequencing efforts have been undertaken to understand the mutational landscape of the coding genome. However, the vast majority of variants occur within non-coding genomic regions. We designed an integrative computational and experimental framework to identify recurrently mutated non-coding regulatory regions that drive tumor progression. Applying this framework to sequencing data from a large prostate cancer patient cohort revealed a large set of candidate drivers. We used (i) in silico analyses, (ii) massively parallel reporter assays, and (iii) in vivo CRISPR interference screens to systematically validate mCRPC drivers. One found enhancer region, GH22I030351, acts on a bidirectional promoter to simultaneously modulate expression of U2-associated splicing factor SF3A1 and chromosomal protein CCDC157. SF3A1 and CCDC157 promote tumor growth in vivo. We nominated a number of transcription factors, notably SOX6, to regulate expression of SF3A1 and CCDC157. Our integrative approach enables the systematic detection of non-coding regulatory regions that drive human cancers.

2025-10-01 | GSE274679 | GEO

Integrative identification of non-coding regulatory regions driving metastatic prostate cancer [MPRA]

2025-10-01 | GSE274698 | GEO